Global Continence
These accolades reflect the confidence of leading experts in our transformative approach to stopping bedwetting through gentle neuromodulation. Soluu™ is redefining pediatric urology, bringing hope and real solutions to families worldwide.
Let's celebrate success - here is the latest from Global Continence!
Better sleep. More confidence. Innovative help for childhood bedwetting.
Lisa Mackey
AUA Innovation Nexus Community (February 2026)
Global Continence is a pioneering healthcare company founded by Dr. Andrew J Kirsch and Dr. Ubirajara Barroso, dedicated to transforming the landscape of Nocturnal Enuresis (NE) treatment. Their flagship product, Soluu®, is a revolutionary bedwetting device that harnesses the power of neuromodulation and remote signaling through non-invasive transcutaneous nerve stimulation (TENS) and a user-friendly app. Soluu® aims to revolutionize NE treatment with over 80% success within two months, as demonstrated in initial studies.
Global Continence attended the inaugural Innovation Nexus Forum in 2023, where they were selected as one of the most exciting startups of that year. Since then, Global Continence has won multiple awards, including the NIH/FDA Midwest Pediatric Device Consortium Prize in 2024 for Soluu, and four out of six pediatric device grants.
In 2025, Global Continence launched their new product The Ultimate Bedwetting Survival Guide, a ground-breaking resource which aims to help parents and children understand, manage and overcome bedwetting.
Having raised over $2 million dollars since the Forum, we at Innovation Nexus are proud to have Global Continence as an alumnus and success story.
To learn more visit: Nexus Alumni Success – Global Continence | AUA Innovation Nexus Exchange
November 2025
Soluu earns the Silver Medal and $50,000 award at the UCSF–Stanford and Midwest Pediatric Device Consortium Pitch Contest in San Francisco! This is the 5th NIH sponsored Pediatric Device Pitch Contest win for Dr. Kirsch and the Global Continence team.
2025
The American Academy of Pediatrics has awarded Dr. Kirsch a Special Recognition Certificate for his continued contributions to pediatric education.
Dr. Kirsch’s groundbreaking work in the treatment of bedwetting has changed countless lives. He’s developed Soluu, a game-changing device designed to help children overcome nighttime bedwetting, and recently published a practical, parent-friendly guide on bedwetting.
2025
Andrew Kirsch, Recognized at Global Continence Inc
Recognized by Atlanta Business Chronicle on July 17th, 2025
2025
Dr. Andrew Kirsch has been recognized for the John W. Duckett, Jr., MD Pediatric Urology Research Excellence Award
The Duckett Award is presented annually to recognize outstanding work in the field of pediatric urology research.
2025
Soluu™ has achieved an extraordinary milestone, securing top recognition at every NIH/FDA-sponsored Pediatric Device Consortium (PDC) event, culminating in a Bronze Medal at the UCSF-Stanford PDC presentation at Stanford School of Medicine in 2025.
This clean sweep solidifies Soluu’s position as a leader in pediatric device innovation.
2024
Soluu earned the NIH/FDA Midwest Pediatric Device Consortium Prize, supported by a consortium led by Nationwide Children's Hospital, The Ohio State University, Cleveland Clinic Children's and Cincinnati Children's Hospital Medical Center.
Soluu Makes It to the Academic Stage
Soluu has been featured in invited international presentations across the globe - USA, Portugal, Mexico, the Dominican Republic, and Brazil. The scientific Medical Community is taking notice as the word spreads about our disruptive innovation in the pediatric incontinence space.
